Saxagliptin is similar in glycaemic variability more effective in metabolic control than acarbose in aged type 2 diabetes inadequately controlled with metformin.

Authors
Category Primary study
JournalDiabetes research and clinical practice
Year 2015
This study compared the effects on glycaemic variability and glucose control between saxagliptin and acarbose as add-on therapies for aged T2DM inadequately controlled with metformin alone. The results showed that compared with acarbose-metformin, saxagliptin-metformin was more effective in glucose control with similar glycaemic variability.
Epistemonikos ID: 4c67ca8e8cd258eafbdf190797f55e7d395f6488
First added on: Nov 22, 2021